Big Pharma and the buying of psychiatry: Outspoken and inspiring psychiatrist E. Fuller Torrey shares many (most) of my concerns about the influence of the pharmaceutical industry on psychiatrists’ practice habits. Here he focuses on the marketing carnivals that international psychiatric symposia have become, essentially buying and selling psychiatrists’ souls. A more comprehensive statement of concern, however, would not focus on the small number of psychiatrists who attend major international conferences and the even smaller number who are given all-expense paid junkets to these conferences even if they are not presenters but only attendees, because their prescribing practices are being bought. In the past decade, marketing representatives have, I am convinced (from watching my colleagues) become the main source of continuing education of psychiatrists, and pharma-funded research the only type of published “scientific” findings published in the major psychiatric journals (for that small subset of practicing psychiatrists who still read the literature). The American Prospect